Quetiapine (Seroquel® and generics) has been available in Canada since 1998. It is approved for schizophrenia, bipolar disorder and, as of 2010, for major depressive disorder (MDD) refractory to treatment with antidepressants.1 It is widely prescribed in low doses for management of sleep disorders, despite lacking approval for this use.2 In 2010 almost $20 million …
